At Epigenomics, we strongly believe in the value of partnerships in which each partner brings its strengths to create synergies in executing our, as well as their, business strategy.

For our commercial partnership, we typically bring in value through our proprietary biomarkers and technologies, while our partners help us in gaining broad customer access or applying our technologies and biomarkers in fields such as drug development and personalized medicine.

Our academic partners bring great value through their scientific know-how, medical expertise and access to patient populations for discovery and validation of new biomarkers for challenging medical diagnostic questions.